| Literature DB >> 19166577 |
Thomas R Jørgensen1, Theo Goosen, Cees A M J J van den Hondel, Arthur F J Ram, Jens J L Iversen.
Abstract
BACKGROUND: The filamentous fungus, Aspergillus niger, responds to nutrient availability by modulating secretion of various substrate degrading hydrolases. This ability has made it an important organism in industrial production of secreted glycoproteins. The recent publication of the A. niger genome sequence and availability of microarrays allow high resolution studies of transcriptional regulation of basal cellular processes, like those of glycoprotein synthesis and secretion. It is known that the activities of certain secretory pathway enzymes involved N-glycosylation are elevated in response to carbon source induced secretion of the glycoprotein glucoamylase. We have investigated whether carbon source dependent enhancement of protein secretion can lead to upregulation of secretory pathway elements extending beyond those involved in N-glycosylation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19166577 PMCID: PMC2639373 DOI: 10.1186/1471-2164-10-44
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Morphology of mycelium in chemostat cultures of . (A) Steady state on xylose (50 h). (B) Steady state on maltose (80 h).
Physiology in chemostat culture.
| Xylose | AB94-85 | 4.06 ± 0.07 | 233 ± 6 | 0.54 ± 0.02 | 1.35 ± 0.04 | 3.40 ± 0.11 | 3.36 ± 0.14 | 1.01 ± 0.02 | 0.68 ± 0.01 | 98 ± 2 |
| ABGT1026 | 3.96 ± 0.07 | 256 ± 18 | 0.53 ± 0.01 | 1.32 ± 0.03 | 3.41 ± 0.10 | 3.42 ± 0.10 | 1.00 ± 0.01 | 0.72 ± 0.02 | 101 ± 3 | |
| Maltose | AB94-85 | 3.68 ± 0.08* | 160 ± 5 | 0.52 ± 0.01 | 1.23 ± 0.03* | 2.92 ± 0.05* | 3.38 ± 0.14 | 0.87 ± 0.05* | 1.98 ± 0.28* | 101 ± 1 |
| ABGT1026 | 3.68 ± 0.12* | 158 ± 24 | 0.52 ± 0.02 | 1.23 ± 0.04* | 2.84 ± 0.17* | 3.57 ± 0.27 | 0.80 ± 0.10* | 1.69 ± 0.24* | 97 ± 2 |
Steady state results of chemostat cultures with xylose or maltose as growth-limiting substrates. Standard deviations ( ± ) are given for mean values of triplicate independent steady state results. Cbiomass, dryweight biomass concentration; Cxylose/maltose, concentration of substrate (NB: maltose as glucose equivalents); Yxs, growth yield on substrate; YxC, growth yield on substrate carbon; qCO2, specific carbon dioxide evolution rate; qO2, specific oxygen consumption rate; RQ, respiratory quotient calculated as the ratio of CO2 production and O2 consumption rates; qprotein-EC, specific production rate of extracellular protein; C-recovery, carbon recovery. Two-tailed t-tests were used to evaluate significance (p < 0.05) of differences in each column (except substrate concentration and carbon recovery).
* results are significantly different from unmarked results in the same column.
† substrate concentration on maltose is given as concentration of glucose released into filtrate after incubation with α-glucosidase.
Figure 2Growth profiles of triplicate , Dry weight biomass concentration (gDW kg-1) as a function of time (h) illustrates growth of three replicate cultures (open square, circle and triangle). Dot-line indicates start of continuous cultivation – exit from batch culture. Dash-line represents the switch to maltose as carbon source after 5 RT with xylose as the growth-limiting substrate. Arrows indicate time-points, where mycelium was harvested for transcriptomic analysis.
Figure 3Signal intensity variation among replicate cultures. Variation is expressed as coefficient of variation (CV) of mean signal intensities of independent triplicate measurements, and shown for steady-state gene-expression of xylose- (A, C) and maltose-limited (B, D) cultures of AB94-85 and ABGT1026. Only genes with Detection call Marginal or Present in at least one of three measurements are shown (expressed genes). Blue and red circles and identifiers indicate maltose-expressed genes involved in xylose/xylan catabolism and clustered fumonisin biosynthesis gene homologs, respectively.
Xylose utilisation metabolic genes with significantly higher expression on xylose compared to maltose.
| ORF | gene name | encoded enzyme (homolog) | fold difference | signal xylose | SD | Signal maltose | SD | p | FDR |
| Xylose conversion: | |||||||||
| An01g03740 | D-xylose reductase | 15.9 | 9,267 | 511 | 1,048 | 1,033 | 4.1·10-3 | 4.5·10-2 | |
| An07g03140 | xylulokinase (Xks1 – | 16.0 | 916 | 103 | 58 | 34 | 2.3·10-5 | 1.3·10-3 | |
| Pentose phosphate pathway – nonoxidative phase: | |||||||||
| An08g06570 | transketolase (Tkl1 – | 1.4 | 5,410 | 439 | 3,522 | 448 | 1.6·10-4 | 4.7·10-3 | |
| An07g03850 | transaldolase (Tal1 – | 1.4 | 5,127 | 615 | 3,257 | 566 | 1.6·10-4 | 4.7·10-3 | |
| An07g03160 | transaldolase (TalB – | 8.9 | 551 | 32 | 60 | 26 | 2.1·10-5 | 1.2·10-3 | |
| Glycolysis/gluconeogenesis: | |||||||||
| An16g05420 | glucose-6-phosphate isomerase (Pgi1 – | 1.7 | 1,481 | 278 | 789 | 61 | 2.5·10-3 | 3.2·10-2 | |
| Pentose phosphate pathway – oxidative phase: | |||||||||
| An02g12140 | glucose-6-phosphate dehydrogenase | 1.5 | 1,588 | 159 | 966 | 111 | 4.5·10-5 | 2.0·10-3 | |
ORF = identifier for open reading frame in A. niger CBS513.88 genome sequence [3]; gene name in A. niger; enzyme encoded by ORF (gene product and species name in parenthesis indicate closest ORF-homolog with characterized function); fold difference reflects ratio of normalized transcript levels on xylose compared to maltose (xylose/maltose); mean signal values of six experiments on each carbon source and standard deviations (SD) is given in Affymetix units; significance of each observation is given by p-value (p) and the Benjamini-Hochberg false discovery rate (FDR).
The 10, most highly and differentially expressed, secreted-carbohydrase genes on xylose or maltose.
| ORF | gene name | encoded enzyme (homolog) | fold difference | signal xylose | SD | signal maltose | SD | p | FDR |
| High expression on maltose (maltose/xylose): | |||||||||
| An03g06550 | glucoamylase | 3.5 | 4,175 | 574 | *12,892 | 805 | 1.8·10-8 | 4.5·10-5 | |
| An04g06920 | extracellular alpha-glucosidase | 25.0 | 468 | 54 | 10,460 | 1,117 | 6.8·10-12 | 8.5·10-8 | |
| An11g03340 | acid alpha-amylase | 100.5 | 37 | 11 | 3,202 | 356 | 3.6·10-10 | 1.1·10-6 | |
| An09g00260 | alpha-galactosidase | 4.9 | 450 | 61 | 1,973 | 310 | 1.8·10-8 | 1.4·10-5 | |
| An12g08280 | extracellular exo-inulinase | 25.2 | 57 | 9 | 1,279 | 44 | 9.9·10-10 | 2.4·10-6 | |
| High expression on xylose (xylose/maltose): | |||||||||
| An01g00780 | endo-1,4-xylanase | 22.3 | 7,846 | 1,169 | 422 | 346 | 1.5·10-4 | 4.6·10-3 | |
| An01g09960 | xylosidase | 43.3 | 5,260 | 205 | 182 | 185 | 1.7·10-4 | 5.1·10-3 | |
| An14g02760 | endo-glucanase | 81.3 | 4,079 | 476 | 56 | 47 | 4.0·10-7 | 1.1·10-4 | |
| An14g05800 | alpha-glucuronidase | 45.0 | 3,619 | 433 | 81 | 45 | 1.4·10-6 | 2.2·10-4 | |
| An09g03300 | alpha-xylosidase | 10.3 | 3,365 | 529 | 438 | 398 | 2.5·10-3 | 3.2·10-2 | |
ORF = identifier for open reading frame in A. niger CBS513.88 genome sequence [3]; gene name in A. niger; enzyme encoded by ORF (gene product and species name in parenthesis indicate closest ORF-homolog with characterized function); fold difference reflects ratio of normalized transcript levels (maltose/xylose or xylose/maltose); mean signal values of six experiments on each carbon source and standard deviations (SD) is given in Affymetix units; significance of each observation is given by p-value (p) and the Benjamini-Hochberg false discovery rate (FDR).
*signal of An03g06550-probeset appears saturated, leading to underestimation of glaA-transcription in maltose-limited chemostat cultures.
Differential expression of secretory pathway genes.
| ORF | gene name | homologous protein in | fold difference | p | FDR |
| Translocation to ER: | |||||
| 1.3 | 1.7·10-4 | 4.9·10-3 | |||
| 1.7 | 1.6·10-5 | 1.1·10-3 | |||
| 1.7 | 2.1·10-5 | 1.2·10-3 | |||
| An01g11630* | SSS1 (YDR086c) – SEC61 complex SU | 1.5 | 1.1·10-3 | 1.8·10-2 | |
| 1.6 | 6.9·10-5 | 2.7·10-3 | |||
| An02g01510 | SEC62 (YPL094c) – SEC63 complex SU | 1.7 | 1.5·10-3 | 2.3·10-2 | |
| An16g08830* | SEC66 (YBR171w) – SEC63 complex SU | 1.8 | 3.5·10-4 | 8.3·10-3 | |
| Cleavage of signal sequence: | |||||
| 1.7 | 2.5·10-5 | 1.4·10-3 | |||
| 1.7 | 2.1·10-5 | 1.2·10-3 | |||
| An01g00560* | SEC11 (YIR022w) – signal peptidase complex SU | 1.7 | 1.7·10-3 | 2.5·10-2 | |
| Glycosylation: | |||||
| 1.6 | 2.3·10-5 | 1.3·10-3 | |||
| An14g00270 | dolichyl-phosphate mannosyltransferase ( | 1.4 | 7.5·10-4 | 1.4·10-2 | |
| An03g04410** | ALG5 (YPL227c) – dolichyl-phosphate glucosyltransferase | 1.6 | 2.8·10-4 | 7.2·10-3 | |
| An02g03240* | ALG7 (YBR243c) – | 1.7 | 2.2·10-4 | 6.0·10-3 | |
| An14g05910* | ALG2 (YGL065c) – mannosyltransferase | 1.9 | 1.3·10-3 | 2.1·10-2 | |
| An04g03130 | mannose-phosphate-dolichol utilization protein ( | 1.6 | 2.1·10-4 | 5.7·10-3 | |
| An08g07020 | ALG9 (YNL219c) – mannosyltransferase | 1.4 | 4.2·10-3 | 4.6·10-2 | |
| An02g12630 | ALG6 (YOR002w) – glucosyltransferase | 1.3 | 1.7·10-3 | 2.5·10-2 | |
| 1.5 | 7.6·10-5 | 2.8·10-3 | |||
| 1.7 | 1.7·10-4 | 5.0·10-3 | |||
| 1.7 | 1.2·10-4 | 3.8·10-3 | |||
| 1.5 | 1.4·10-4 | 4.4·10-3 | |||
| 1.5 | 9.7·10-5 | 3.4·10-3 | |||
| 1.7 | 4.1·10-5 | 1.9·10-3 | |||
| An04g06990 | MNS1 (YJR131w) – class I α-mannosidase | 1.3 | 2.0·10-3 | 2.8·10-2 | |
| An06g01510 | class I α-mannosidase ( | 1.7 | 2.1·10-4 | 5.7·10-3 | |
| An12g00340 | ER glucosyl hydrolase, Edem ( | 1.4 | 1.0·10-3 | 1.7·10-2 | |
| 1.5 | 1.9·10-5 | 1.2·10-3 | |||
| 1.3 | 1.5·10-4 | 4.7·10-3 | |||
| An15g04810 | MNT2 (YGL257c) – α-1,3-mannosyltransferase | 0.7 | 1.4·10-3 | 2.2·10-2 | |
| An08g04450 | GDA1 (YEL024w) – guanosine diphosphatase | 1.3 | 7.7·10-4 | 1.4·10-2 | |
| Folding: | |||||
| 1.8 | 1.1·10-5 | 3.6·10-3 | |||
| An02g05890 | thioredoxin domain protein, TXNDC5 ( | 1.3 | 1.3·10-3 | 2.1·10-2 | |
| An18g02020* | protein disulfide isomerase | 1.6 | 2.3·10-4 | 6.1·10-3 | |
| An01g04600** | MPD1 (YOR288c) – protein disulfide isomerase | 1.9 | 6.0·10-4 | 1.2·10-2 | |
| An16g07620** | ERO1 (YML130c) – thiol oxidase | 1.5 | 3.1·10-3 | 2.1·10-2 | |
| 1.6 | 1.5·10-4 | 4.6·10-3 | |||
| An08g07810 | FAD1 (YDL045c) – FAD synthase | 1.3 | 1.3·10-3 | 2.1·10-2 | |
| 2.2 | 5.0·10-5 | 2.2·10-3 | |||
| An18g06470 | ERJ5 (YFR041c) – ER located DNA-J protein | 1.5 | 3.4·10-4 | 8.2·10-3 | |
| An01g13220** | LHS1 (YKL073w) – ER lumen Hsp70 chaperone | 1.9 | 2.8·10-4 | 7.1·10-3 | |
| An01g06670 | FPR2 (YDR519w) – peptidyl-prolyl isomerase | 1.7 | 1.9·10-3 | 2.7·10-2 | |
| Trimming and quality control of N-glycosylated folded proteins: | |||||
| 1.7 | 3.3·10-6 | 3.8·10-4 | |||
| 1.5 | 1.1·10-5 | 8.5·10-4 | |||
| 1.7 | 2.6·10-5 | 1.4·10-3 | |||
| 2.3 | 6.5·10-6 | 5.8·10-4 | |||
| Vesicular transport of proteins between ER and Golgi: | |||||
| 1.4 | 2.2·10-5 | 1.3·10-3 | |||
| An02g01690 | SEC31 (YDL195w) – COPII complex SU | 1.6 | 2.7·10-4 | 7.0·10-3 | |
| An08g10650 | SEC24 (YIL109c) – COPII complex SU | 1.5 | 1.6·10-3 | 2.3·10-2 | |
| 1.6 | 1.4·10-4 | 4.3·10-3 | |||
| An08g03590 | EMP24 (YGL200c) – COPII vesicle membrane component | 1.4 | 2.8·10-3 | 3.4·10-2 | |
| An04g01780 | ERP1 (YAR002c-a) – COPII vesicle component | 1.5 | 1.3·10-3 | 2.1·10-2 | |
| 1.5 | 1.3·10-4 | 4.1·10-3 | |||
| 1.4 | 1.2·10-5 | 8.9·10-4 | |||
| 1.5 | 2.1·10-5 | 1.2·10-3 | |||
| 1.6 | 7.6·10-5 | 2.8·10-3 | |||
| An07g09960 | BET1 (YIL004c) – v-SNARE | 1.3 | 5.0·10-3 | 5.1·10-2 | |
| An07g02170 | BOS1 (YLR078c) – v-SNARE | 1.4 | 1.8·10-3 | 2.6·10-2 | |
| An08g06780* | USO1 (YDL058w) – SNARE complex assembly protein | 1.8 | 2.2·10-4 | 6.0·10-3 | |
| An02g06870 | RAD50-interacting protein 1 ( | 1.2 | 2.3·10-3 | 3.0·10-2 | |
| An04g01990 | centromere protein ZW10 ( | 1.3 | 1.1·10-3 | 1.8·10-2 | |
| An04g08690 | GSG1 (YDR108w) – TRAPP complex SU | 1.3 | 4.9·10-3 | 5.0·10-2 | |
| 1.5 | 8.1·10-6 | 6.8·10-4 | |||
| 2.1 | 1.2·10-5 | 9.0·10-4 | |||
| 1.8 | 1.7·10-5 | 1.1·10-3 | |||
| 1.4 | 2.8·10-5 | 1.5·10-3 | |||
| 1.3 | 1.8·10-5 | 1.1·10-3 | |||
| An07g02190 | SEC7 (YDR170c) – guanine nucleotide exchange factor | 1.3 | 2.7·10-3 | 3.4·10-2 | |
| An18g02490 | GEA2 (YEL022w) – guanine nucleotide exchange factor on ARF | 1.3 | 6.8·10-4 | 1.3·10-2 | |
| 1.4 | 3.5·10-5 | 1.7·10-3 | |||
| 1.4 | 2.9·10-5 | 1.5·10-3 | |||
| 1.5 | 3.2·10-5 | 1.6·10-3 | |||
| 1.4 | 1.8·10-4 | 5.3·10-3 | |||
| An02g05870 | SEC27 (YGL137w) – COPI complex, β ' SU | 1.5 | 5.4·10-4 | 1.1·10-2 | |
| 1.3 | 1.1·10-4 | 3.8·10-3 | |||
| An04g05250* | RER2 (YBR002c) – retention of ER membrane proteins | 1.2 | 3.7·10-3 | 4.2·10-2 | |
| 1.4 | 1.1·10-4 | 3.8·10-3 | |||
| Other processes in the secretory pathway: | |||||
| An11g02650 | AGE2 (YIL044c) – ARF GTPase activating protein effector | 1.1 | 3.6·10-3 | 4.0·10-2 | |
| An16g03590 | SEC14 (YMR079w) – phosphatidylinositol/-choline transfer protein | 1.2 | 3.3·10-3 | 3.8·10-2 | |
| An04g02070 | CHC1 (YGL206c) – clathrin, heavy chain | 1.2 | 2.7·10-3 | 3.4·10-2 | |
| An16g02490 | APL2 (YKL135c) – β-adaptin | 1.5 | 3.3·10-3 | 3.8·10-2 | |
| An16g03010 | VPS4 (YPR173c) – vacuolar protein sorting AAA-ATPase | 0.8 | 3.1·10-3 | 3.7·10-2 | |
| An02g05380 | VPS33 (YLR396c) – vacuolar protein sorting | 1.3 | 2.5·10-4 | 6.5·10-3 | |
| An14g05130 | VPS16 (YPL045w) – vacuolar protein sorting | 0.8 | 4.0·10-3 | 4.4·10-2 | |
| An01g02910 | VPS52 (YDR484w) – vacuolar protein sorting | 1.4 | 4.2·10-3 | 4.6·10-2 | |
| An02g11720 | AMS1 (YGL156w) – vacuolar α-mannosidase | 0.8 | 2.3·10-3 | 3.0·10-2 | |
| An06g01200 | EMP70 (YLR083c) – conserved endosomal membrane protein | 1.3 | 3.2·10-4 | 7.8·10-3 | |
| An03g06900 | SEC10 (YLR166c) – exocyst complex SU | 1.2 | 3.5·10-4 | 8.3·10-3 | |
| An02g04030 | EXO70 (YJL085w) – exocyst complex SU | 1.3 | 3.7·10-3 | 4.1·10-2 | |
| An01g11960 | BFR1 (YOR198c) – component of mRNP complex | 1.4 | 2.3·10-4 | 6.1·10-3 | |
| An04g01950 | STE24 (YJR117w) – zinc metalloprotease | 1.3 | 2.7·10-4 | 6.9·10-3 | |
| An07g10050 | microtubule binding protein HOOK3 ( | 1.2 | 2.7·10-3 | 3.4·10-2 | |
| Protein misfolding (UPR and ER associated degradation): | |||||
| 0.7 | 1.1·10-4 | 3.7·10-3 | |||
| An01g07900 | GCN4 (YEL009c) – bZIP transcription factor | 0.8 | 2.6·10-3 | 3.3·10-2 | |
| 1.6 | 4.7·10-5 | 2.1·10-3 | |||
| An01g08980 | ORM1 (YGR038w) – conserved ER protein | 0.7 | 3.8·10-4 | 8.8·10-3 | |
| An15g00640 | DER1 (YBR201w) – involved in ER associated protein degradation | 1.4 | 2.2·10-3 | 3.0·10-2 | |
| An16g07970 | HRD1 (YOL013c) – ubiquitin-protein ligase | 1.3 | 8.3·10-4 | 1.5·10-2 | |
| 1.6 | 6.4·10-5 | 2.5·10-3 | |||
| An09g06110 | UBC7 (YMR022w) – ubiquitin conjugating enzyme | 1.2 | 3.0·10-3 | 3.6·10-2 | |
| An04g01720 | HLJ1 (YMR161w) – DnaJ co-chaperone | 1.3 | 2.6·10-4 | 6.8·10-3 | |
ORF = identifier for open reading frame in A. niger CBS513.88 genome sequence [3]; gene name in A. niger; protein encoded by ORF-homolog in S. cerevisiae and yeast protein function if available; fold difference reflects ratio of normalized transcript levels on maltose compared to xylose (maltose/xylose); significance of each observation is given by p-value (p) and the Benjamini-Hochberg false discovery rate (FDR).
Bold indicates observations with very high significance (FDR ≤ 0.005).
* and ** denote genes with increased transcription during ER-stress with 2/3 or 3/3 types of protein folding stress [15], repectively.
Figure 4Functional classification of differentially expressed genes (open bars indicate number of genes with higher transcript levels on xylose; hatched bars represent genes higher expressed on maltose). (A) Representation of major functional categories (Funcat) among differentially expressed genes. (B) Subcellular localization of differentially expressed genes. Unclassified ORFs: high on xylose, 40% (213/528); high on maltose, 30% (214/712).
Figure 5Differentially expressed genes in sub-Funcats of Fig. 4A. (A) 06 – Protein fate. (B) 08 – Cellular transport and transport mechanisms. (C) 05 – Protein synthesis.